Literature DB >> 10762302

Anti-coagulant monitoring service delivery: a comparison of costs of hospital and community outreach clinics.

A Davies1, M J Buxton, D L Patterson, J Webster-King.   

Abstract

Anti-coagulated patients are monitored at regular intervals to ensure that their warfarin dosage is appropriate for their target International Normalized Ratio. The traditional setting for this monitoring has been the hospital clinic. Technological advances allow-- and with growing numbers of anti-coagulated patients, are leading to-- greater provision of monitoring clinics outside the hospital, at a more convenient location nearer patients' homes. This paper discusses the differences in organization between a hospital clinic and one set in the community (although provided by the hospital), and compares their costs. The comparison demonstrates the greater average cost per appointment in outreach of pound sterling 13.12 under current arrangements. Estimates are presented of incremental cost per appointment of pound sterling 3.93 and pound sterling 15.88 for a 10% increase in weekly patient numbers put through hospital and outreach clinics, respectively. Cost estimates are also presented for suggested alterations to hospital clinics that may reduce patient inconvenience, and the conditions under which outreach provision might be expanded at comparable cost to hospital provision are also examined.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10762302     DOI: 10.1046/j.1365-2257.2000.00282.x

Source DB:  PubMed          Journal:  Clin Lab Haematol        ISSN: 0141-9854


  2 in total

1.  Neonatal hearing screening: modelling cost and effectiveness of hospital- and community-based screening.

Authors:  Eva Grill; Kai Uus; Franz Hessel; Linda Davies; Rod S Taylor; Juergen Wasem; John Bamford
Journal:  BMC Health Serv Res       Date:  2006-02-23       Impact factor: 2.655

2.  Factors determining patients' intentions to use point-of-care testing medical devices for self-monitoring: the case of international normalized ratio self-testing.

Authors:  Syed Ghulam Sarwar Shah; Julie Barnett; Jasna Kuljis; Kate Hone; Richard Kaczmarski
Journal:  Patient Prefer Adherence       Date:  2012-12-28       Impact factor: 2.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.